COVID-19 Risk Factors
literature database & meta-analysis

Last update : 2020-08-04 16:24:58 (GMT+2)   |  276 factors investigated   |  1766 estimates included  |  219 articles processed  |  QC progress: 51%

Associated factors

Outcomes

Filters

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.
Green: significant protective factor
Red: significant risk factor
§ adjusted estimate (see article details)
estimated using data reported in the article
Outcome Risk category Risk [exposed vs. unexposed] Risk estimate (95% CI) Author [URL] View QC
COVID-19 (severe/critical) Findings Radiological finding on admission [-400 ~ -200 Hounsfield unit (%) vs. Normal] Odds ratio: 1.010 (0.990-1.041) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [> -200 Hounsfield units (%) vs. Normal] Odds ratio: 0.990 (0.970-1.010) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase of consolidation percentage in right lower lobe vs. Not applicable] Odds ratio: 1.050 (0.970-1.150) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase of consolidation percentage in right middle lobe vs. Not applicable] Odds ratio: 1.060 (1.000-1.130) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase of consolidation percentage in right upper lobe vs. Not applicable] Odds ratio: 1.130 (1.030-1.250) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase of consolidation percentage in left lower lobe vs. Not applicable] Odds ratio: 1.060 (0.990-1.130) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase of consolidation percentage in left upper lobe vs. Not applicable] Odds ratio: 1.150 (1.010-1.320) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase in ground-glass opacity percentage in left lower lobe vs. Not applicable] Odds ratio: 1.100 (0.990-1.230) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase in ground-glass opacity percentage in right middle lobe vs. Not applicable] Odds ratio: 0.990 (0.850-1.140) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase in ground-glass opacity percentage in right upper lobe vs. Not applicable] Odds ratio: 1.000 (0.820-1.220) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase in ground-glass opacity percentage in left lower lobe vs. Not applicable] Odds ratio: 1.100 (0.990-1.230) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase in ground-glass opacity percentage in left upper lobe vs. Not applicable] Odds ratio: 1.050 (0.920-1.210) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [1% increase of total lesion volume vs. Not applicable] Odds ratio: 0.750 (0.500-1.130) § Yu
COVID-19 (severe/critical) Findings Radiological finding on admission [Lung lobes involved vs. Normal] Odds ratio: 1.500 (0.850-2.640) § Yu
COVID-19 (severe/critical) Patient characteristics Age [1 year increase vs. Not applicable] Odds ratio: 1.040 (1.010-1.060) § Yu
COVID-19 (death) Treatment Concomitant medication [Treated with anticoagulats vs. Not received] Hazard ratio: 0.790 (0.350-1.800) Klok
COVID-19 (death) Complications Thrombotic complications [Present vs. Not present] Hazard ratio: 5.400 (2.400-12.000) Klok
COVID-19 (death) Laboratory Findings LDH [Abnormal vs. Normal] Odds ratio: 1.010 (1.000-1.030) § Benussi
COVID-19 (death) Laboratory Findings CRP [Abnormal vs. Normal] Odds ratio: 1.000 (0.990-1.010) § Benussi
COVID-19 (death) Laboratory Findings Platelet count [Abnormal vs. Normal] Odds ratio: 0.980 (0.970-0.990) § Benussi
COVID-19 (death) Complications Sequential Organ Failure Assessment (SOFA) score [1 unit increase vs. Not applicable] Odds ratio: 4.470 (1.210-16.500) § Benussi
COVID-19 (death) Patient characteristics Age [1 year increase vs. Not applicable] Odds ratio: 1.080 (0.990-1.180) § Benussi
COVID-19 (severe/fatal) Treatment Treatment for COVID-19 [Treated with remdesivir vs. Not received] Hazard ratio: 0.950 (0.550-1.640) Wang
COVID-19 (clinical improvement) Treatment Treatment for COVID-19 [Treated with remdesivir vs. Not received] Hazard ratio: 1.230 (0.870-1.750) Wang
Prolonged duration of SARS-CoV-2 shedding Status Hospital lenght of stay [1 day increase vs. Not applicable] Odds ratio: 1.604 (1.262-2.040) § Qi
Prolonged duration of SARS-CoV-2 shedding Treatment Treatment for COVID-19 [Treated with Immunoglobulin vs. Not received] Odds ratio: 0.098 (0.009-1.102) § Qi
Prolonged duration of SARS-CoV-2 shedding Treatment Treatment for COVID-19 [Treated with Glucocorticoids vs. Not received] Odds ratio: 3.965 (0.425-37.006) § Qi
Prolonged duration of SARS-CoV-2 shedding Laboratory Findings Serum ferritin [Abnormal vs. Normal] Odds ratio: 0.969 (0.219-4.291) § Qi
Prolonged duration of SARS-CoV-2 shedding Laboratory Findings Lymphocyte count [Abnormal vs. Normal] Odds ratio: 1.703 (0.328-8.836) § Qi
Prolonged duration of SARS-CoV-2 shedding Laboratory Findings Partial Pressure of Oxygen (PaO2) [1 unit increase vs. Not applicable] Odds ratio: 0.990 (0.969-1.011) § Qi
Prolonged duration of SARS-CoV-2 shedding Status Time from symptom onset to admission [1 day increase vs. Not applicable] Odds ratio: 1.740 (1.296-2.337) § Qi
Prolonged duration of SARS-CoV-2 shedding Symptoms Body temperature [Fever present vs. Not present] Odds ratio: 5.200 (1.190-22.726) § Qi
Prolonged duration of SARS-CoV-2 shedding Symptoms Sputum production [Present vs. Not present] Odds ratio: 1.745 (0.448-6.793) § Qi
COVID-19 (severe/fatal) Treatment Concomitant medication [Treated with biologics vs. Not received] Odds ratio: 0.410 (0.030-6.590) Damiani
COVID-19 (severe/critical) Treatment Concomitant medication [Treated with biologics vs. Not received] Odds ratio: 3.410 (0.210-54.550) Damiani
COVID-19 (any condition) Treatment Concomitant medication [Treated with biologics vs. Not received] Odds ratio: 3.430 (2.250-5.730) Damiani
COVID-19 (death) Treatment Treatment for COVID-19 [Treated with corticosteroid vs. Not received] Hazard ratio: 0.154 (0.033-0.724) § Goicoechea
COVID-19 (death) Patient characteristics Age [1 year increase vs. Not applicable] Hazard ratio: 1.064 (0.996-1.138) § Goicoechea
COVID-19 (death) Treatment Treatment for COVID-19 [Treated with Lopinavir–Ritonavir vs. Not received] Hazard ratio: 0.969 (0.107-8.741) § Goicoechea
COVID-19 (death) Treatment Treatment for COVID-19 [Treated with Azithromycin vs. Not received] Hazard ratio: 0.057 (0.005-0.697) § Goicoechea
COVID-19 (death) Patient characteristics Age [1 year increase vs. Not applicable] Hazard ratio: 1.116 (1.008-1.236) § Goicoechea
COVID-19 (death) Laboratory Findings LDH [1 unit increase vs. Not applicable] Hazard ratio: 1.006 (1.001-1.011) § Goicoechea
COVID-19 (death) Patient characteristics Age [1 year increase vs. Not applicable] Hazard ratio: 1.092 (0.984-1.212) § Goicoechea
COVID-19 (death) Laboratory Findings Lymphocyte count [1 unit increase vs. Not applicable] Hazard ratio: 0.996 (0.992-1.000) § Goicoechea
COVID-19 (death) Patient characteristics Age [1 year increase vs. Not applicable] Hazard ratio: 1.058 (0.956-1.171) § Goicoechea
COVID-19 (death) Status Time of hemodialysis [1 month increase vs. Not applicable] Hazard ratio: 1.008 (1.001-1.015) § Goicoechea
COVID-19 (death) Patient characteristics Age [1 year increase vs. Not applicable] Hazard ratio: 1.070 (0.990-1.156) § Goicoechea
COVID-19 (death) Comorbidities Chronic liver disease [Present vs. Not present] Hazard ratio: 1.510 (1.210-1.880) § Docherty
COVID-19 (death) Comorbidities Cancer [Present vs. Not present] Hazard ratio: 1.130 (1.020-1.240) § Docherty
COVID-19 (death) Comorbidities Dementia [Present vs. Not present] Hazard ratio: 1.400 (1.280-1.520) § Docherty
If a relevant publication escaped our attention, please contact us.